NCT02376582 - Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

HIV/AIDS

Interventions

BIOLOGICAL

DNA

DNA co-administered with protein at month 0, 1 and 6

BIOLOGICAL

AIDSVAX B/E

Protein co-administered with DNA at month 0,1 and 6

Trial Locations (2)

Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI), Entebbe

Medical Research Council (MRC) /Uganda Virus Research Institute (UVRI), Masaka